Developing New Drugs for Schizophrenia: From Animals to the Clinic-Reference-Cited by-同舟云学术

Developing New Drugs for Schizophrenia: From Animals to the Clinic

Published:2008 Issue: Volume: Page:199-261
ISSN:
Container-title:Animal and Translational Models for CNS Drug Discovery
language:
Short-container-title:

Author:

Jones Declan N.C.,Gartlon Jane E.,Minassian Arpi,Perry William,Geyer Mark A.

Publisher

Elsevier

Reference428 articles.

1. Picchioni, M.M. and Murray, R.M. (2007). Schizophrenia. BMJ, 335: 91–95.

2. Mortality among patients with schizophrenia and reduced psychiatric hospital care;Heile;Psychol Med,2005

3. Gitkin, A., Harris, G., Birchenough, J. et al. (2001). Nervous Breakdown. A Detailed Analysis of the Neurology Market. UBS Warburg, New York, pp. 256–264

4. American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington DC.

5. World Health Organisation (1992). The ICD-10 Classification of Mental and Behavioural Disorders, Geneva.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Relevance of Animal Models of Social Isolation and Social Motivation for Understanding Schizophrenia: Review and Future Directions;Schizophrenia Bulletin;2023-08-01

2. A Novel Phosphodiesterase 1 Inhibitor DSR-141562 Exhibits Efficacies in Animal Models for Positive, Negative, and Cognitive Symptoms Associated with Schizophrenia;Journal of Pharmacology and Experimental Therapeutics;2019-10-02

3. A Role for Oxytocin in the Etiology and Treatment of Schizophrenia;Frontiers in Endocrinology;2015-06-03

4. Current Views on the Role of MicroRNAs in Psychosis;MicroRNAs in Medicine;2013-11-01

5. Metabotropic Glutamate Receptors for New Treatments in Schizophrenia;Novel Antischizophrenia Treatments;2012